Cardiac Interventional ICE Imaging Trial

Exclusion Criteria

• •Anticipated vascular access (e.g., femoral vein, inferior vena cava, subclavian vein, internal jugular vein) cannot meet the procedure needs.
• •PLT \<100\*109/L or INR \>1.5.
• •Intracardiac blood clots or severe peripheral vascular disease (e.g., deep vein thrombosis, aneurysm, atherosclerosis).
• •Sepsis, pyemia, or severe systemic infection.
• •NYHA Class IV.
• •History of cardiac or related cardiac areas surgery within 6 months.
• •Inability to tolerate post procedure oral anticoagulants or antiplatelet drugs.
• •Inability to tolerate or cooperate with the procedure.
• •Pregnant or lactating women, women with a positive pregnancy test result within 7 days before enrollment.
• •Participation in other clinical trials of drugs, biological agents or devices within 3 months before screening.
• •Other exclusive circumstances determined by the investigators, where the subject is deemed unsuitable for enrollment.